医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ResearchDx, the Leading Contract Diagnostics Organization, Expands Operations into India

2013年11月25日 AM09:55
このエントリーをはてなブックマークに追加


 

MUMBAI

ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets.

As part of this initiative, ResearchDx will be presenting at the BioPharma India Convention 2013 Meeting in Mumbai, India, held November 25th-26th. “We are proud to be involved as a sponsor of the BioPharma India Convention 2013 meeting. This meeting brings together the key diagnostics and biopharmaceutical companies in the region and is the ideal venue to highlight our services” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx.

As a Contract Diagnostics Organization, ResearchDx is targeting two major areas for Indian clients. “We can provide a strategic partnership to Indian companies looking to develop companion diagnostics or in vitro diagnostic products for the local, US or European markets. We provide a full range of companion diagnostics and in vitro diagnostics services” said Dr. Mathew Moore, Co-Founder and Principal at ResearchDx.

In addition, ResearchDx provides comprehensive services to assist International Clinical Laboratories obtain US CLIA certification, as well as various additional Clinical Laboratory accreditations such as ISO or College of American Pathologists (CAP). “International CLIA certification, and ISO or CAP accreditation provides our clients with a competitive edge. These licensures have enabled our clients to successfully compete for multi-national based clinical trial studies,” said Dr. Philip Cotter.

ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx offers the services and solutions to meet complex diagnostics development needs. ResearchDx’s primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting. Additional information is available at www.researchdx.com.

CONTACT

Media:
ResearchDx
Philip D. Cotter, PhD, FACMG,
FFSc(RCPA)
866-225-9195 / 510-332-0477
pcotter@researchdx.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • レスメド後援の研究で在宅酸素療法と在宅非侵襲的換気療法の併用が費用対効果の高いCOPD治療法であると判明
  • Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of Clinical Oncology (ASCO) and the Congress of the European Hematology Association (EHA) Annual Meetings
  • Cerveau Technologies, Inc.与日本东京都老人综合研究所签订研究协议
  • 继美国和英国之后,中国向Personalis, Inc.签发ACE©技术专利,扩大了其在国际上的知名度
  • セルヴォー・テクノロジーズが日本の東京都健康長寿医療センター研究所と研究契約を締結